𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Argatroban Anticoagulation in Conjunction with Glycoprotein IIb/IIIa Inhibition in Patients Undergoing Percutaneous Coronary Intervention: An Open-Label, Nonrandomized Pilot Study

✍ Scribed by Ik-Kyung Jang; Bruce E. Lewis; William H. Matthai; Neal S. Kleiman

Book ID
106543664
Publisher
Springer US
Year
2004
Tongue
English
Weight
105 KB
Volume
18
Category
Article
ISSN
0929-5305

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Stenting and glycoprotein IIb/IIIa inhib
Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: Findings from the global registry of acute coronary events (GRACE)
✍ Gilles Montalescot; Frans Van de Werf; Dietrich C. Gulba; Álvaro Avezum; David B πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 119 KB πŸ‘ 2 views

## Abstract Stenting and GP IIb/IIIa inhibition are promising adjunctive therapies in PCI. The Global Registry of Acute Coronary Events (GRACE) is a registry of unselected patients with acute coronary syndromes, allowing for the study of treatments in a real‐world environment. Data from GRACE patie

Association Between Angiographic Complic
Association Between Angiographic Complications and Clinical Outcomes Among Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome) Angiographic Substudy
✍ Yuri B. Pride; Satishkumar Mohanavelu; Cafer Zorkun; Vijayalakshmi Kunadian; Rob πŸ“‚ Article πŸ“… 2012 πŸ› American College of Cardiology 🌐 English βš– 385 KB